Positioning political buying, disclosed 2026-09-10
Options put/call open interest 0.25, read 2026-11-05
Ethical passes the values gate
Price115.27 USD
Fair value109.00
Ethical score84.8/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation88.79+29.8% to today ✓Markdown gives way to Accumulation
2026-09-14Read Markdown89.23+29.2% to today Markup gives way to Markdown after a 14% rise in 11 weeks
2026-07-02Read Markup78.48+46.9% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Stanley Black & Decker holds its Markup at $115.27. The statistical read favours the buyers, held for 50 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 50 days
Price at the screen
$115.27
Valuation
25.29 trailing · 16.40 forward price to earnings
Values screen
PASS· score 84.8
Beta
1.17
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
28.23%
Below 33%
Interest-bearing debt is just 28.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.97%
Below 49%
Money owed to the company is 5.0% of assets, under the 49% limit.
Pass
Revenue purity
1.31%
Below 5%
Only 1.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Stanley Black & Decker clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 28%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SWK's ethical verdict changes
Today SWK passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades above our $109.00 fair value estimate, weak competitive moat, 0.40% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 5.8% above the base estimate.
Where our models see it going: fair-value estimate $109.00, with a range of $94.61 to $157.68, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tools Giant Trades Below Its Fair Value
Picture a builder grabbing the same power tool on every job site from Texas to Toronto. Stanley Black & Decker sits at the heart of that everyday demand, yet the shares change hands at just 14.5 times forward earnings with an 18 percent margin of safety to our fair value.
Revenue edges up 3 percent, profit margins sit at 2 percent and return on equity is only 4 percent, yet the ethical screen clears without issue and the business still throws off cash from its core tools and outdoor range.
The low multiple looks tempting until you remember this is a cyclical industry with a weak moat. Peak earnings can flatten fast when housing slows, and analyst targets cluster around 89 dollars, below the current price. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SWK trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Accumulation$104.62-2.0%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Accumulation$106.71+3.2%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Accumulation$103.44+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$103.44+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Accumulation$103.44+3.1%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Accumulation$100.37+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Accumulation$100.37+8.5%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$92.48+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$92.48+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91.
2026-10-18Accumulation$92.48+4.2%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it buy, with a mean price target of $91.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
